Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”

The industry has spent decades optimizing distribution strategies to meet faster timelines. Now, it’s time to think about sustainability.

The FDA says it wants to phase out mandatory animal testing requirements for drug approval. What comes next?

As biologics become more complex, mass spec becomes more indispensable than ever in the drug developer’s toolbox.

Our latest news roundup reports on changes at Novo Nordisk, AbbVie’s ADC accelerated approval, Regeneron’s new acquisition, and more.

We ask an analyst how pharma companies can weather the volatile economic environment and the Trump administration’s tariffs.

Helping biopharma manufacturers to accelerate their time to market, with sustainable practices; here’s how Ecolab is making a difference

Our latest news roundup reports on research targeting solid tumors, a personalized CRISPR gene therapy for a young infant, a comedy show to raise mone

Discussing the challenges facing small rare disease-focussed biotechs, and the successes of advancing treatments.

From academia in Milan to professional development in the UK, Valo Therapeutics CEO Marcella Origgi shares her journey.